Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Free-floating long-term vascularized mesenchymal organoids.

iScience·2026

Same author

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation.

Blood vessels, thrombosis & hemostasis·2025

Same author

Prospects of current AXL-targeting therapies in early phase cancer trials.

Expert opinion on investigational drugs·2025

Same author

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.

Nature communications·2025

Same author

Discovery of Novel TYRO3/MERTK Dual Inhibitors.

Journal of medicinal chemistry·2025

Same author

Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitors.

European journal of medicinal chemistry·2025

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

Gray zone lymphomas in pediatric patients.

Xiayuan Liang¹, Brian Greffe, Bruce Cook

¹Department of Pathology, The Children's Hospital, Aurora, CO, USA. liang.xiayuan@tchden.org

Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

|March 25, 2010

Summary

Gray zone lymphomas are rare lymphoid malignancies challenging to classify. This study reviews two pediatric cases, highlighting diagnostic challenges and treatment strategies for these difficult-to-diagnose cancers.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

Related Experiment Videos

Last Updated: Jun 14, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

Area of Science:

Hematology
Oncology
Pathology

Background:

Gray zone lymphomas are lymphoid malignancies unclassifiable into a single entity.
The 2008 WHO Classification identified two types: intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma, or DLBCL and classical Hodgkin lymphoma (cHL).

Observation:

These rare lymphomas pose diagnostic challenges, particularly in pediatric patients.
This manuscript reports two pediatric cases of gray zone lymphoma.

Findings:

The study reviews clinicopathologic features, treatment options, and outcomes for gray zone lymphoma.
Accurate diagnosis is crucial as it directly impacts patient management strategies.

Implications:

This review provides insights into the management of uncommon gray zone lymphomas in children.
Understanding these challenging cases can improve diagnostic accuracy and therapeutic approaches for pediatric lymphoid malignancies.